COTINGA PHARMACEUTICALS
Company Overview
Industries
Social Media Profiles
About Cotinga Pharmaceuticals
Description
A biotechnology firm focused on innovative treatments, Critical Outcome Technologies Inc. specializes in developing novel therapeutics, notably COTI-2, a promising candidate targeting mutant p53 proteins to combat various cancers, enhancing the likelihood of successful outcomes in drug discovery.
Specialties
Novel cancer therapeutics
COTI-2 drug development
Targeting mutant p53 proteins
Clinical stage drug discovery
Innovative biotechnology solutions
Products & Services
Cancer Treatment Therapies
Small Molecule Activators
Drug Discovery Services
Biotechnology Research
Clinical Development Solutions
Contact Information
No contact information available
Competitors & Similar Companies(6)
Agenus Inc.
Blueprint Medicines Corporation
Reddy's Laboratories Ltd.
Syndax Pharmaceuticals
Amgen Inc.
Iovance Biotherapeutics
News & Media
Search Terms:
cotinga pharmaceuticals
Search Topics:
AcquisitionAI: Product LaunchInvestment: Approval FundingProject: Bid and AuctionBusiness ExpansionFinancing and FundraisingInvestmentJoint VentureLeadership Change (CXO)MergerPartnershipProduct LaunchPublic Offering (IPO)RebrandingReorganizationRestructuringValuation
Loading...
Frequently Asked Questions about Cotinga Pharmaceuticals
Where is Cotinga Pharmaceuticals located?
The headquarter of Cotinga Pharmaceuticals is located in Boston, Massachusetts, United States
What is the official website of Cotinga Pharmaceuticals?
The official website of Cotinga Pharmaceuticals is https://www.criticaloutcome.com
What industry does Cotinga Pharmaceuticals belong to?
Cotinga Pharmaceuticals belongs to the Biotechnology industry.
What are the specialties of Cotinga Pharmaceuticals?
Cotinga Pharmaceuticals specializes in Novel cancer therapeutics, COTI-2 drug development, Targeting mutant p53 proteins, Clinical stage drug discovery, Innovative biotechnology solutions.
What products and services is Cotinga Pharmaceuticals likely to offer?
Cotinga Pharmaceuticals offers Cancer Treatment Therapies, Small Molecule Activators, Drug Discovery Services, Biotechnology Research, Clinical Development Solutions.
Who are the competitors of Cotinga Pharmaceuticals?
Competitors of Cotinga Pharmaceuticals are Agenus Inc., Blueprint Medicines Corporation, Reddy's Laboratories Ltd., Syndax Pharmaceuticals, Amgen Inc., Iovance Biotherapeutics.
What does Cotinga Pharmaceuticals do?
A biotechnology firm focused on innovative treatments, Critical Outcome Technologies Inc. specializes in developing novel therapeutics, notably COTI-2, a promising candidate targeting mutant p53 proteins to combat various cancers, enhancing the likelihood of successful outcomes in drug discovery.